{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:29:25Z","timestamp":1773934165756,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI127024"],"award-info":[{"award-number":["1R01AI127024"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10461-021-03504-5","type":"journal-article","created":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:03:13Z","timestamp":1641600193000},"page":"1504-1516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Attitudes About Analytic Treatment Interruption (ATI) in HIV Remission Trials with Different Antiretroviral Therapy (ART) Resumption Criteria"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3053-7453","authenticated-orcid":false,"given":"Holly L.","family":"Peay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Rennie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Jean","family":"Cadigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Gwaltney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thidarat","family":"Jupimai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nittaya","family":"Phanuphak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eug\u00e8ne","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donn J.","family":"Colby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuchanart","family":"Ormsby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sin\u00e9ad C.","family":"Isaacson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandhya","family":"Vasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Sacdalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peeriya","family":"Prueksakaew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khunthalee","family":"Benjapornpong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jintanat","family":"Ananworanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail E.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,8]]},"reference":[{"key":"3504_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000484","author":"Y Wen","year":"2018","unstructured":"Wen Y, Bar KJ, Li JZ. Lessons learned from HIV antiretroviral treatment interruption trials. Curr Opin HIV AIDS. 2018. https:\/\/doi.org\/10.1097\/COH.0000000000000484.","journal-title":"Curr Opin HIV AIDS"},{"issue":"5","key":"3504_CR2","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/COH.0000000000000489","volume":"13","author":"N Eyal","year":"2018","unstructured":"Eyal N, Holtzman LG, Deeks SG. Ethical issues in HIV remission trials. Curr Opin HIV AIDS. 2018;13(5):422\u20137.","journal-title":"Curr Opin HIV AIDS"},{"key":"3504_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-019-0240-4","author":"C Muccini","year":"2019","unstructured":"Muccini C, Crowell TA, Kroon E, Sacdalan C, Ramautarsing R, Seekaew P, et al. Leveraging early HIV diagnosis and treatment in Thailand to conduct HIV cure research. AIDS Res Ther. 2019. https:\/\/doi.org\/10.1186\/s12981-019-0240-4.","journal-title":"AIDS Res Ther"},{"issue":"4","key":"3504_CR4","first-page":"270","volume":"44","author":"GE Henderson","year":"2018","unstructured":"Henderson GE, Peay HL, Kroon E, Cadigan RJ, Meagher K, Jupimai T, et al. Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk\/benefit assessment. J Med Ethics. 2018;44(4):270\u20136.","journal-title":"J Med Ethics"},{"issue":"3","key":"3504_CR5","doi-asserted-by":"publisher","first-page":"e25260","DOI":"10.1002\/jia2.25260","volume":"22","author":"GE Henderson","year":"2019","unstructured":"Henderson GE, Waltz M, Meagher K, Cadigan RJ, Jupimai T, Isaacson S, et al. Going off antiretroviral treatment in a closely monitored HIV \u201ccure\u201d trial: longitudinal assessments of acutely diagnosed trial participants and decliners. J Int AIDS Soc. 2019;22(3):e25260.","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"3504_CR6","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1016\/S2352-3018(19)30053-0","volume":"6","author":"TA Crowell","year":"2019","unstructured":"Crowell TA, Colby DJ, Pinyakorn S, Sacdalan C, Pagliuzza A, Intasan J, et al. Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet HIV. 2019;6(5):e297\u2013306.","journal-title":"Lancet HIV"},{"issue":"7","key":"3504_CR7","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/cid\/ciz417","volume":"70","author":"M Stecher","year":"2019","unstructured":"Stecher M, Cla\u00dfen A, Klein F, Lehmann C, Gruell H, Platten M, et al. Systematic review and meta-analysis of treatment interruptions in human immunodeficiency virus (HIV) type 1\u2013infected patients receiving antiretroviral therapy: implications for future HIV cure trials. Clin Infect Dis. 2019;70(7):1406\u201317. https:\/\/doi.org\/10.1093\/cid\/ciz417.","journal-title":"Clin Infect Dis"},{"issue":"7632","key":"3504_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nature20583","volume":"540","author":"EN Borducchi","year":"2016","unstructured":"Borducchi EN, Cabral C, Stephenson KE, Liu J, Abbink P, Ng\u2019ang\u2019a D, et al. Ad26\/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys. Nature. 2016;540(7632):284\u20137.","journal-title":"Nature"},{"key":"3504_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan8848","author":"MC Sneller","year":"2017","unstructured":"Sneller MC, Justement JS, Gittens KR, Petrone ME, Clarridge KE, Proschan MA, et al. A randomized controlled safety\/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aan8848.","journal-title":"Sci Transl Med"},{"key":"3504_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(19)30052-9","author":"B Julg","year":"2019","unstructured":"Julg B, Dee L, Ananworanich J, Barouch DH, Bar K, Caskey M, et al. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials\u2014report of a consensus meeting. Lancet HIV. 2019. https:\/\/doi.org\/10.1016\/S2352-3018(19)30052-9.","journal-title":"Lancet HIV"},{"key":"3504_CR11","unstructured":"Jefferys R. Community recommendations for clinical research involving antiretroviral treatment interruption in adults. 2018. https:\/\/www.treatmentactiongroup.org\/wp-content\/uploads\/2018\/11\/community_recs_clinical_research_final.pdf. Accessed 11 Oct 2021."},{"issue":"2","key":"3504_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/QAD.0000000000002058","volume":"33","author":"R Palich","year":"2019","unstructured":"Palich R, Ghosn J, Chaillon A, Boilet V, Nere M-L, Chaix M-L, et al. Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial. AIDS. 2019;33(2):279\u201384. https:\/\/doi.org\/10.1097\/QAD.0000000000002058.","journal-title":"AIDS"},{"issue":"10","key":"3504_CR13","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/infdis\/jiz611","volume":"221","author":"A Ugarte","year":"2020","unstructured":"Ugarte A, Romero Y, Tricas A, Casado C, Lopez-Galindez C, Garcia F, et al. Unintended HIV-1 infection during analytical therapy interruption. J Infect Dis. 2020;221(10):1740\u20132. https:\/\/doi.org\/10.1093\/infdis\/jiz611.","journal-title":"J Infect Dis"},{"key":"3504_CR14","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2019.0118","author":"JSY Lau","year":"2020","unstructured":"Lau JSY, Smith MZ, Allan B, Martinez C, Power J, Lewin SR, et al. Perspectives on analytical treatment interruptions in people living with HIV and their health care providers in the landscape of HIV cure-focused studies. AIDS Res Hum Retrovir. 2020. https:\/\/doi.org\/10.1089\/aid.2019.0118.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"220 Suppl 1","key":"3504_CR15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/infdis\/jiz173","volume":"220","author":"N Eyal","year":"2019","unstructured":"Eyal N, Deeks SG. Risk to nonparticipants in HIV remission studies with treatment interruption: a symposium. J Infect Dis. 2019;220(220 Suppl 1):S1\u20134.","journal-title":"J Infect Dis"},{"issue":"1","key":"3504_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S2055-6640(20)30009-1","volume":"6","author":"MJ Peluso","year":"2020","unstructured":"Peluso MJ, Dee L, Campbell D, Taylor J, Hoh R, Rutishauser RL, et al. A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption. J Virus Erad. 2020;6(1):34\u20137.","journal-title":"J Virus Erad"},{"issue":"2","key":"3504_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/medethics-2015-103120","volume":"43","author":"D Evans","year":"2017","unstructured":"Evans D. An activist\u2019s argument that participant values should guide risk-benefit ratio calculations in HIV cure research. J Med Ethics. 2017;43(2):100\u20133.","journal-title":"J Med Ethics"},{"issue":"2","key":"3504_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2055-6640(20)31143-2","volume":"1","author":"HL Peay","year":"2015","unstructured":"Peay HL, Henderson GE. What motivates participation in HIV cure trials? A call for real-time assessment to improve informed consent. J Virus Erad. 2015;1(2):51\u20133.","journal-title":"J Virus Erad"},{"key":"3504_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/S2055-6640(20)30295-8","author":"K Dub\u00e9","year":"2017","unstructured":"Dub\u00e9 K, Evans D, Sylla L, Taylor J, Weiner BJ, Skinner A, et al. Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US. J Virus Erad. 2017. https:\/\/doi.org\/10.1016\/S2055-6640(20)30295-8.","journal-title":"J Virus Erad"},{"issue":"1","key":"3504_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/aid.2017.0067","volume":"34","author":"K Dub\u00e9","year":"2018","unstructured":"Dub\u00e9 K, Evans D, Dee L, Sylla L, Taylor J, Skinner A, et al. \u201cWe need to deploy them very thoughtfully and carefully\u201d: perceptions of analytical treatment interruptions in HIV cure research in the United States-a qualitative inquiry. AIDS Res Hum Retrovir. 2018;34(1):67\u201379.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"11","key":"3504_CR21","doi-asserted-by":"publisher","first-page":"e0187489","DOI":"10.1371\/journal.pone.0187489","volume":"12","author":"C Proti\u00e8re","year":"2017","unstructured":"Proti\u00e8re C, Spire B, Mora M, Poizot-Martin I, Pr\u00e9au M, Doumergue M, et al. Patterns of patient and healthcare provider viewpoints regarding participation in HIV cure-related clinical trials. Findings from a multicentre French survey using Q methodology (ANRS-APSEC). PLoS ONE. 2017;12(11):e0187489\u2013e0187489.","journal-title":"PLoS ONE"},{"issue":"2","key":"3504_CR22","doi-asserted-by":"publisher","first-page":"e25443","DOI":"10.1002\/jia2.25443","volume":"23","author":"C Protiere","year":"2020","unstructured":"Protiere C, Arnold M, Fiorentino M, Fressard L, Leli\u00e8vre JD, Mimi M, et al. Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS-APSEC study: a discrete choice experiment. J Int AIDS Soc. 2020;23(2):e25443\u2013e25443.","journal-title":"J Int AIDS Soc"},{"key":"3504_CR23","unstructured":"CDC. National health and nutrition examination survey. CDC. 2015. https:\/\/wwwn.cdc.gov\/Nchs\/Nhanes\/2013-2014\/HSQ_H.htm. Accessed 11 Oct 2021."},{"issue":"60","key":"3504_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","volume":"1","author":"E Broadbent","year":"2006","unstructured":"Broadbent E, Petrie K, Main J, Weinman J. The brief illness perception questionnaire (BIPQ). J Psychosom Res. 2006;1(60):631\u20137.","journal-title":"J Psychosom Res"},{"key":"3504_CR25","unstructured":"Peay, H.L., Jupimai, T., Ormsby, N., Rennie, S., Cadigan, R.J, Kuczynski, K., Isaacson, S.C., Phanuphak, N., Kroon, E., Ananworanich, J., Vasan, S., Prueksakaew, P., Intasan, J., Henderson GE. Perceived health and stigma among a population of individuals diagnosed with acute HIV: report from the SEARCH010 cohort. In: AIDS 2020: virtual [conference presentation]. San Francisco: International AIDS Society."},{"key":"3504_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200203080-00012","author":"H Knobel","year":"2002","unstructured":"Knobel H, Alonso J, Casado JL, Collazos J, Gonz\u00e1lez J, Ruiz I, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS. 2002. https:\/\/doi.org\/10.1097\/00002030-200203080-00012.","journal-title":"AIDS"},{"key":"3504_CR27","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12889-016-3274-8","volume":"16","author":"T Khawcharoenporn","year":"2016","unstructured":"Khawcharoenporn T, Chunloy K, Apisarnthanarak A. Uptake of HIV testing and counseling, risk perception and linkage to HIV care among Thai university students. BMC Public Health. 2016;16:556.","journal-title":"BMC Public Health"},{"issue":"5","key":"3504_CR28","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1007\/s10461-011-0025-9","volume":"16","author":"CE Golin","year":"2012","unstructured":"Golin CE, Earp JA, Grodensky CA, Patel SN, Suchindran C, Parikh M, et al. Longitudinal effects of SafeTalk, a motivational interviewing-based program to improve safer sex practices among people living with HIV\/AIDS. AIDS Behav. 2012;16(5):1182\u201391.","journal-title":"AIDS Behav"},{"issue":"5","key":"3504_CR29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s11904-020-00516-z","volume":"17","author":"N Phanuphak","year":"2020","unstructured":"Phanuphak N, Ramautarsing R, Chinbunchorn T, Janamnuaysook R, Pengnonyang S, Termvanich K, et al. Implementing a status-neutral approach to HIV in the Asia-pacific. Curr HIV\/AIDS Rep. 2020;17(5):422\u201330. https:\/\/doi.org\/10.1007\/s11904-020-00516-z.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"220 Suppl 1","key":"3504_CR30","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1093\/infdis\/jiz164","volume":"220","author":"N Eyal","year":"2019","unstructured":"Eyal N, Magalhaes M. Is it ethical to isolate study participants to prevent HIV transmission during trials with ananalytical treatment interruption? J Infect Dis. 2019;220(220 Suppl 1):S19\u201321. https:\/\/doi.org\/10.1093\/infdis\/jiz164.","journal-title":"J Infect Dis"},{"issue":"6","key":"3504_CR31","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/inthealth\/ihaa060","volume":"12","author":"GE Henderson","year":"2020","unstructured":"Henderson GE, Rennie S, Corneli A, Peay HL. Cohorts as collections of bodies and communities of persons: insights from the SEARCH010\/RV254 research cohort. Int Health. 2020;12(6):584\u201390.","journal-title":"Int Health"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03504-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-021-03504-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03504-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T19:34:00Z","timestamp":1649705640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-021-03504-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["3504"],"URL":"https:\/\/doi.org\/10.1007\/s10461-021-03504-5","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,8]]},"assertion":[{"value":"13 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DC has received research grant support from Gilead Sciences. All other authors report no conflicts of interest or competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the IRB of the Faculty of Medicine, Chulalongkorn University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All participants provided informed consent to participate in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The study informed consent included a section indicating that de-identified study data would be reported.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}